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ABSTRACT
Fluorescence-guided surgery is a recently developed technique in minimally invasive 
surgery in which a fluorescent dye is used to complement the surgeon’s judgment in 
making real-time intraoperative assessment of organ vascularization and proper tissue 
perfusion. This technique has been adopted in several different surgical subspecialties 
with positive results, particularly in hepatobiliary and colorectal surgery. More recently, 
it has also been applied in bariatric surgery, with the aim of reducing the incidence of 
leaks. This paper reviews the relevant literature on the topic.
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Introduction:
The alarming prevalence of obesity, with its related 
burden of metabolic consequences, is a well-known 
problem. Metabolic surgery has been recognized as the 
most effective treatment for achieving significant weight 
loss as well as tangible improvements in glycemic 
control and a reduction of overall cardiovascular risk.
[1] Surgery for obesity is also recognized as a safe 
treatment, with  mortality rates comparable to those 
of other common procedures (e.g., appendectomy, 
cholecystectomy, hysterectomy), ranging from 0.3% to 
2%.[2] The occurrence of major adverse events at 30 days 
vary from 5.0% for Roux-en-Y gastric bypass to 2.6% for 
sleeve gastrectomy.[3] Technological improvements as 
well as the institution of accredited bariatric surgery 
programs are two of the main factors contributing to these 
favorable results.[4] One recently introduced technique 
in the field of bariatric surgery is indocyanine green 
(ICG) fluorescence angiography (ICG-FA). Indocyanine 
green, a fluorescent dye approved by the FDA and EMA 
for use in medical diagnostics, has been routinely used 
for years in ophthalmology, but recently several other 
fields of application have also been described in the 
literature, most notably colorectal, hepatobiliary, and 
oncologic surgery.[5]  ICG absorbs near-infrared light 
at wavelengths between 800 to 810 nm and becomes 
fluorescent at 830 nm, when excited by a laser source 
or by a near-infrared light at 820 nm wavelength.[6] 
Fluorescence can be visualized by special laparoscopic 
cameras and rendered on screen in several different 
colors, depending on the proprietary filters applied by 
each camera maker. Our paper reviews the literature on 
application of ICG in obesity surgery.
Methods:
This systematic review was performed in accordance 
with the PRISMA guidelines.[7] The study population 
included patients undergoing any bariatric surgical 
operation. The intervention object of the analysis was 
intraoperative ICG-FA assessment of vascularization. 
Any comparison was considered. Outcome: post-
operative complications. The following exclusion 
criteria were selected: preclinical studies, non-bariatric 
surgical procedures, surgeries on obese patients 
performed for other reasons other than weight loss, and 
language other than English. Duplicate studies were 
removed. A systematic search of the literature (Figure 
1) was undertaken by the two authors in PubMed, 
Google Scholar, and Embase, current through May 5, 
2020, and included additional papers identified from 
the references. Search terms were “indocyanine green”, 
“ICG”, “fluorescence angiography”, “ICG AND bariatric 
surgery”, “ICG AND obesity”, “ICG AND leak”, and 
“dehiscence”. The following data were extracted from 
each study: age, preoperative BMI, length of stay, and 
postoperative complications.[8]
 
 
Figure 1: Flowchart of the records selection process. 
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Results:
A total of 103 articles were identified during the search 
(Figure 1). After removal of duplicates, 75 papers were 
screened, of which 69 were not pertinent to the study and 
thus were excluded. Six eligible studies were initially 
identified, one of which was removed for noncompliance 
with the inclusion criteria. Ultimately, five studies were 
included for the analysis, all published after 2008. Our 
search found no comparative studies.
One of the studies was a case report[9]; the remaining 
four included studies [10-13] from prospectively 
maintained databases analyzed retrospectively (Table 1). 
A total of 240 patients were included in the studies. The 
majority of patients (N = 144) underwent laparoscopic 
sleeve gastrectomy, another 95 underwent robotic 
Roux-en-Y gastric bypass (R-RYGB), and 1 underwent 
a laparoscopic RYGB combined with a Rossetti 
fundoplication. No demographic data were available 
for 86 patients, not having been reported in the study 
by Ortega et al.[12] No intraoperative complications 
were reported in any of the studies. Only one leak 
occurred postoperatively, in a patient who underwent a 
laparoscopic sleeve gastrectomy, as reported by Di Furia 
et al.[11] ICG was used intravenously to assess proper 
vascularization of the staple line in four of five studies. 
In the study by Hagen et al[13], however, ICG was used 
to assess intraoperative leaks and was administered 
via nasogastric tube, mixed with methylene blue dye 
and saline solution. No studies reported side effects 
following ICG administration.
Some of the studies included in our review described the 
effect of ICG administration on operative times, finding 
no significant increase. However, the lack of comparative 
studies prevented the drawing of any conclusions about 
the advantages of this technique over standard practice. 
Nor can any conclusion be drawn regarding the most 
appropriate dose and administration regimen of ICG, 
owing to a lack of information in some of the studies and 
the heterogeneity of application seen in the remainder.
Discussion:
At present, there is no gold standard method for 
conducting intraoperative assessment of tissue 
perfusion. Traditionally, visual evaluation and tactile 
testing of pulsating blood vessels have been most 
frequently adopted. The recent introduction of ICG in 
minimally invasive surgery has provided a potential 
solution to the problem, but its use is debated among the 
surgical community. The use of ICG in bariatric surgery 
was introduced only recently, with the aim of assessing 
adequate perfusion of the gastric tubule during sleeve 
gastrectomy and of bowel anastomoses in RYGB, so as to 
reduce leaks. However, in view of the low incidence of 
leaks in bariatric surgery[4], study of a large number of 
patients may be needed to detect any difference between 
standard practice and ICG, representing a potential 
obstacle to doing so. Consensus on optimal ICG dosage 
and timing of administration will also be needed. 
Notably, although some acute allergic reactions have 
been reported, the intravenous use of ICG is regarded as 
generally safe.[14]
Accordingly, we see revisional bariatric surgery as a 
potentially promising application of ICG because of 
the challenges provided by anatomical alterations and 
the need to achieve optimal perfusion in suboptimal 
tissues. A significant limitation of this technique is the 
current impossibility of providing objective quantitative 
assessment of fluorescence intensity, which would 
provide a more reliable way of demonstrating the value 
of this technology. In our opinion, this is an important 
need that should be addressed by novel studies. 
Our study has several limitations. Data presented 
among the various studies were highly heterogeneous, 
preventing any comparison. All studies included were 
single-centered and adopted different techniques for ICG 
administration and imaging detection systems; indeed, 
some studies lacked such information altogether. 
Conclusion:
ICG fluorescence is a widely adopted technique in 
multiple surgical specialties but has been introduced 
to bariatric surgery only recently. Its intravenous 
use allows the execution of real-time intraoperative 
angiography and assessment of tissue perfusion, thus 
potentially preventing leaks as well as perfusion-related 
complications. Currently no evidence suggests that its 
use can reduce postoperative complications in bariatric 
surgery. We think that ICG use may be a valuable aid 
to the surgeon for intraoperative real-time assessment 
of vascularization and tissue perfusion. More studies, 
particularly randomized controlled trials, comparing 
its application with standard vision are needed to 
investigate the potential advantages of ICG use in 
routine practice.
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Authors Patients 
(N) 
Age  
(mean ± std dev) 
pre-op BMI  
(mean Kg/m2± std dev) 
Type of 
surgery 
Post-op 
complications 
Olmi et al. (2019)[9] 1 38 43 RYGB None reported 
Frattini et al. (2015)[10] 15 42 45  Sleeve None reported 
Di Furia et al. (2019)[11] 43 46.04 40.73 Sleeve 1 leak 
Ortega et al. (2018)[12] 86 - - Sleeve None reported 
Hagen et al. (2019)[13] 95 43.9 ± 11.1 43.5 ± 6.4 R-RYGB None reported 
Table 1: Characteristics of the included studies.
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